Cargando…
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341450/ https://www.ncbi.nlm.nih.gov/pubmed/28270175 http://dx.doi.org/10.1186/s13063-017-1848-0 |
| _version_ | 1782512993114783744 |
|---|---|
| author | Busard, Celine Menting, Stef van Bezooijen, Sun-Jine van den Reek, Juul Hutten, Barbara Prens, Errol de Jong, Elke van Doorn, Martijn Spuls, Phyllis |
| author_facet | Busard, Celine Menting, Stef van Bezooijen, Sun-Jine van den Reek, Juul Hutten, Barbara Prens, Errol de Jong, Elke van Doorn, Martijn Spuls, Phyllis |
| author_sort | Busard, Celine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5341450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53414502017-03-10 Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial Busard, Celine Menting, Stef van Bezooijen, Sun-Jine van den Reek, Juul Hutten, Barbara Prens, Errol de Jong, Elke van Doorn, Martijn Spuls, Phyllis Trials Erratum BioMed Central 2017-03-07 /pmc/articles/PMC5341450/ /pubmed/28270175 http://dx.doi.org/10.1186/s13063-017-1848-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Busard, Celine Menting, Stef van Bezooijen, Sun-Jine van den Reek, Juul Hutten, Barbara Prens, Errol de Jong, Elke van Doorn, Martijn Spuls, Phyllis Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title | Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title_full | Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title_fullStr | Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title_full_unstemmed | Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title_short | Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| title_sort | erratum to: optimizing adalimumab treatment in psoriasis with concomitant methotrexate (optimap): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341450/ https://www.ncbi.nlm.nih.gov/pubmed/28270175 http://dx.doi.org/10.1186/s13063-017-1848-0 |
| work_keys_str_mv | AT busardceline erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT mentingstef erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT vanbezooijensunjine erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT vandenreekjuul erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT huttenbarbara erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT prenserrol erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT dejongelke erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT vandoornmartijn erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial AT spulsphyllis erratumtooptimizingadalimumabtreatmentinpsoriasiswithconcomitantmethotrexateoptimapstudyprotocolforapragmaticsingleblindedinvestigatorinitiatedrandomizedcontrolledtrial |